Rewind Pause Forward

Portfolio

Sarissa Biomedical

Sarissa Biomedical is developing a range of minimally invasive, microelectrode electrochemical sensors for the measurement of the purines and other neurochemicals, as indicators of neurological activity/disorders.

Click here to view our full portfolio

0

Mercia Fund Management is an active investor in early-stage technology companies located in Central England.

Investment provision
Portfolio
Business support
Sources of assistance

Quick Contact